Johns Hopkins All Children's Hospital

Institute for Clinical and Translational Research

Pursuing evidence-based treatments and cures for children

Research is at the heart of all we do at Johns Hopkins All Children’s Hospital. By providing pediatric patients with access to innovative research opportunities, we help advance the diagnosis, treatment, and prevention of pediatric onset diseases and their adverse outcomes.

The Johns Hopkins All Children’s Institute for Clinical and Translational Research, under the leadership of Director Neil Goldenberg, M.D., Ph.D., engages investigators who share a collective passion not only for what the clinical and translational research reveals, but also how one conducts the research (i.e., process is as important as product). This emphasis permeates the education and training activities that the Institute conducts with residents, fellows and faculty/clinicians. The institute also works in parallel with the Institute for Fundamental Biomedical Research, advancing a growing number of interdisciplinary research initiatives and teams that bridge the basic and clinical/translational sciences.

The hospital is a member of the national Institute for Advanced Clinical Trials (I-ACT) for Children, and leaders within the Institute for Clinical and Translational Research serve on several of I-ACT’s leadership committees and task forces. More than 100 full- and part-time faculty of the Johns Hopkins University are based at Johns Hopkins All Children’s and engage in clinical and translational research. Leveraging work and accomplishments made since 2012 at All Children’s, the Johns Hopkins All Children’s Institute for Clinical and Translational Research has launched several research centers and programs, addressing common themes that span the organization’s existing institutes and departments, including:

  • early-phase clinical trials to study innovative pediatric uses of existing medications (the Center for Pediatric Early-Phase Trials);
  • research focused on pediatric health equity, in particular health care access and health outcomes (the Program in Pediatric Health Equity Research);
  • and education and training programs for the next generation of clinical/translational scientists focused on child health and disease (the Center for Pediatric Clinical/Translational Research Education, Training and Engagement).

Additional centers and programs will be launched over the next two years. These centers and programs will serve as scientific “hubs” for the development of innovative clinical/translational research studies, methods, and grant applications by its researchers and their collaborators in Baltimore and beyond, as well as the publication of original, peer-reviewed research manuscripts for dissemination of new scientific and medical knowledge.  

The Johns Hopkins All Children’s institute is integrated within the Baltimore-based Johns Hopkins Institute for Clinical and Translational Research, which receives about $15 million per year from the National Institutes of Health to support investigators as they move discoveries into practice. The institute structures enhance collaboration across Johns Hopkins Medicine campuses.

Related Articles

Confronting the Impact of COVID-19 on Children and Families Using a Research Focus on the Social Determinants of Health

Physician researchers at Johns Hopkins All Children’s Hospital and their collaborators have embarked on an innovative research study designed to understand the social, economic and health impact of the COVID-19 on families in the Tampa Bay area.

Read More

Johns Hopkins All Children’s Expert Appointed to Chair International Pediatric Committee on Clotting and Bleeding Disorders

Neil Goldenberg, M.D., Ph.D., chairs the committee, which is part of the International Society on Thrombosis and Haemostasis, a professional membership organization of more than 5,000 clinicians, researchers and educators working together to improve the lives of patients in more than 100 countries.

Read More

Johns Hopkins All Children’s Launches Study of Anti-clotting Medications’ Impact on COVID-19 Patients

As patients around the world with severe COVID-19 illness are presenting with higher rates of vascular blood clots, researchers at Johns Hopkins All Children’s Hospital have launched a national clinical trial to study the use of anti-clotting medications to treat children with the coronavirus and related diseases.

Read More

Johns Hopkins All Children’s Researchers Featured in The Journal of Pediatrics Supplement on Translational Research

Neil Goldenberg, M.D., Ph.D., associate dean for research at Johns Hopkins All Children’s and a professor of pediatrics and medicine at Johns Hopkins University School of Medicine, served as co-editor of the supplement.

Read More

Research Study on Bleeding in Scoliosis Surgeries Lays Groundwork for Future Discovery

Researchers at Johns Hopkins All Children’s Hospital published a study that investigated the factors that contribute to blood loss during scoliosis surgery.

Read More